Based on 6 analysts giving stock ratings to PMV Pharmaceuticals Inc in the past month.
In the current month, PMVP has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PMVP average Analyst price target in the last month is 4.000.
Based on analysts' estimates, PMVP EPS is projected to reach -0.253 in FY2026Q4, following reported EPS of -0.519 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.52, while PMV Pharmaceuticals IncPMVP's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.25.